April 7 (Reuters) - Biogen Inc BIIB.O:
ALLOY THERAPEUTICS ENTERS INTO MULTI-TARGET COLLABORATION AND LICENSE AGREEMENT WITH BIOGEN FOR USE OF ALLOY’S ANTICLASTIC™ ASO PLATFORM
ALLOY: THROUGH THIS COLLABORATION, BIOGEN WILL APPLY PLATFORM TO ADVANCE ANTISENSE THERAPEUTICS AGAINST MULTIPLE UNDISCLOSED TARGETS